Stroke Thrombolysis With Tenecteplase to Reduce Emergency Department Spread of Coronavirus Disease 2019 and Shortages of Alteplase.

Warach, Steven J; Saver, Jeffrey L

Warach, Steven J; Saver, Jeffrey L.

Warach SJ; Department of Neurology, Dell Medical School, University of Texas at Austin, Austin.
Saver JL; Ascension Texas, Austin.

JAMA Neurol ; 77(10): 1203-1204, 2020 10 01.

Article in English | MEDLINE | ID: covidwho-657564

Subject(s)

COVID-19/prevention & control; Emergency Service, Hospital/standards; Fibrinolytic Agents/administration & dosage; Tenecteplase/administration & dosage; Thrombolytic Therapy/standards; Tissue Plasminogen Activator/administration & dosage; COVID-19/complications; Fibrinolytic Agents/supply & distribution; Humans; Tenecteplase/supply & distribution; Thrombosis/drug therapy; Tissue Plasminogen Activator/supply & distribution; Workflow

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombolytic Therapy / Tissue Plasminogen Activator / Emergency Service, Hospital / Fibrinolytic Agents / Tenecteplase / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: JAMA Neurol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google